Grifols SA
GIKLY
|
$4.56
132.75%
260
|
Manufacturing
(0.0% 1d) (14.1% 1m) (-10.6% 1y) (0.0% 2d) (0.0% 3d) (-1.9% 7d) (-14.33% volume)
Earnings Calendar:
Market Cap: $ 1,709,720,221
https://www.grifols.com
Sec Filling | Patents | 2020 employees
(ES) Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people around the world. Its four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative solutions and services that are sold in more than 100 countries. Pioneers in the plasma industry, Grifols operates a growing network of donation centers worldwide. It transforms collected plasma into essential medicines to treat chronic, rare and, at times, life-threatening conditions. As a recognized leader in transfusion medicine, Grifols also offers a comprehensive portfolio of solutions designed to enhance safety from donation to transfusion. In addition, the company supplies tools, information and services that enable hospitals, pharmacies and healthcare professionals to efficiently deliver expert medical care. Grifols, with more than 24,000 employees in 30 countries and regions, is committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership. In 2019, Grifols' economic impact in its core countries of operation was EUR 8.5 billion. The company also generated 148,000 jobs, including indirect and induced.
diagnostics 3d msa
add to watch list Paper trade email alert is off
Press-releases
Hepatitis B and C diagnostics market size to increase by USD 2.05 billion, Technavio
Published: 2024-03-27 (Crawled : 14:30) - prnewswire.com
DHR | $240.34 0.28% 0.0% 3.2M
|
Health Technology
|
| O: 0.56%
H: 0.16%
C: -0.43%
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
VIR | $8.36 -2.45% -2.51% 660K
|
Health Technology
|
| O: 0.4%
H: 2.3%
C: 0.9%
GILD | $67.32 -0.64% -0.64% 5M
|
Health Technology
|
| O: 0.7%
H: 0.19%
C: 0.12%
hepatitis diagnostics market
Global Subcutaneous Immunoglobulin Market Analysis & Forecast 2024-2034, By Product, Application, End-user and Region
Published: 2024-03-21 (Crawled : 23:00) - prnewswire.com
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
BAX | $39.57 -1.17% -0.56% 2.7M
|
Health Technology
|
| O: 0.14%
H: 0.36%
C: -0.31%
global market
In-vitro Diagnostics Market Size to Grow by USD 22.17 billion from 2024 to 2028, Analysing market growth on Reagents and Kits Segment, Technavio
Published: 2024-03-14 (Crawled : 06:00) - prnewswire.com
GIKLY | $4.56 132.75% 260
|
Manufacturing
|
| O: -8.02%
H: 0.0%
C: 0.0%
TMO | $554.55 -0.6% 0.0% 1M
|
Health Technology
|
| O: -0.39%
H: 0.7%
C: -1.03%
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
in-vitro diagnostics growth market
Biologics Contract Development And Manufacturing Organization (CDMO) Market to grow by USD 10.63 billion, The availability of cost-efficient resources to boost market growth, Technavio
Published: 2024-03-12 (Crawled : 05:00) - prnewswire.com
GIKLY | $4.56 132.75% 260
|
Manufacturing
|
| O: -4.79%
H: 0.0%
C: -0.23%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.2%
H: 0.0%
C: -2.57%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: -1.55%
H: 0.23%
C: -0.03%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: 0.0%
contract market
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims against Grifols S.A.
Published: 2024-01-26 (Crawled : 15:30) - prnewswire.com
GIKLY | $4.56 132.75% 260
|
Manufacturing
|
| O: 3.14%
H: 0.0%
C: 0.0%
ASRT | $0.7975 -2.08% -2.12% 590K
|
Health Technology
|
| O: -0.32%
H: 4.09%
C: -0.6%
ALVR | $0.7349 -1.5% -1.52% 270K
|
Health Technology
|
| O: -0.06%
H: 4.36%
C: 2.91%
potential
Plasma Fractionation Market to grow by USD 10.00 billion, 5.81% YOY growth expected in 2024, North America to Experience Maximum Growth - Technavio
Published: 2024-01-26 (Crawled : 03:00) - prnewswire.com
CSLLY | $89.5 3.3% 44K
|
n/a
|
| O: 0.21%
H: 0.22%
C: 0.21%
GIKLY | $4.56 132.75% 260
|
Manufacturing
|
| O: 3.14%
H: 0.0%
C: 0.0%
ACN | $313.94 0.21% 0.0% 2.9M
|
Technology Services
|
| O: -0.01%
H: 0.6%
C: -0.23%
KMDA | $5.15 -0.96% -0.97% 16K
|
Health Technology
|
| O: 0.89%
H: 1.05%
C: 0.88%
ADMA 4 | $6.16 3.01% 2.92% 1.8M
|
Health Technology
|
| O: 0.98%
H: 1.36%
C: -0.78%
america expected growth market
Hematological Disorders Pipeline Report 2023 - Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Published: 2024-01-23 (Crawled : 01:00) - prnewswire.com
GIKLY | $4.56 132.75% 260
|
Manufacturing
| Email alert
Add to watchlist
GIFLF | $8.46 42.22% 610
|
Health Technology
| Email alert
Add to watchlist
companies report disorders pipeline key
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation - GRFS, GIKLY, GIFOF, GIFLF
Published: 2024-01-18 (Crawled : 23:00) - prnewswire.com
BTAFF | $29.2187 44.6% 1.8K
|
Consumer Non-Durables
|
| O: -0.73%
H: 1.46%
C: 0.68%
BTI | $28.38 -0.46% -0.03% 4.7M
|
Consumer Non-Durables
|
| O: 0.27%
H: 0.48%
C: 0.14%
GRFS | $6.78 3.67% 3.54% 1.5M
|
Health Technology
|
| O: -1.04%
H: 4.04%
C: 1.2%
BROG | $1.185 -12.22% -13.92% 550K
|
Finance
|
| O: 0.39%
H: 6.67%
C: -3.92%
trial
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation - GRFS, GIKLY, GIFOF, GIFLF
Published: 2024-01-10 (Crawled : 21:00) - prnewswire.com
MBLY | $30.13 -3.89% -4.05% 2.8M
|
|
| O: -1.7%
H: 3.32%
C: 3.09%
GIFLF | $8.46 42.22% 610
|
Health Technology
|
| O: 1.3%
H: 0.0%
C: 0.0%
GIKLY | $4.56 132.75% 260
|
Manufacturing
|
| O: -9.54%
H: 0.0%
C: 0.0%
GRFS | $6.78 3.67% 3.54% 1.5M
|
Health Technology
|
| O: -7.24%
H: 2.68%
C: -7.23%
global
Pharmaceutical Contract Manufacturing Market to grow by USD 58 billion from 2022 to 2027, North America to account for 41% of market growth - Technavio
Published: 2024-01-05 (Crawled : 23:00) - prnewswire.com
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
| Email alert
Add to watchlist
BAX | $39.57 -1.17% -0.56% 2.7M
|
Health Technology
| Email alert
Add to watchlist
TMO | $554.55 -0.6% 0.0% 1M
|
Health Technology
| Email alert
Add to watchlist
GIKLY | $4.56 132.75% 260
|
Manufacturing
| Email alert
Add to watchlist
GIFLF | $8.46 42.22% 610
|
Health Technology
| Email alert
Add to watchlist
america contract growth market
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Last 48 Hours Insiders Buying
KFS P 481 | $8.6 1.06% 0.0% 15K
|
Finance
|
20:30
AINC | $4.83 -1.43% 1.45% 98K
|
Finance
|
20:30
RVP P 3587 | $1.065 -1.39% 0.47% 49K
|
Health Technology
|
17:00
TPL P 12 | $586.93 0.52% 0.0% 50K
|
Miscellaneous
|
16:01
HNRA | $2.76 16.95% -1.81% 400K
|
n/a
|
15:02
TGEN | $0.67 39.71% 16K
|
Utilities
|
14:30
RMCF | $3.6492 -7.2% 9.2K
|
Consumer Non-Durables
|
20:10